Diseases Archives - Page 24 of 43 - Pharma Journalist

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women

Neurocrine Biosciences files NDA for opicapone for Parkinson’s disease

Sandoz asserts FDA’s approval for initiation of Glatopa

FDA clearance sought for Roche’s Factor II and Factor V test on cobas 4800 system

FDA sanctions breakthrough treatment for specific kind of Prostate Cancer

J&J Pharmaceuticals announce approval of ERLEADA by FDA for NM-CRPC patients

Mallinckrodt affirms enlisting of first patient for ExpressGraft C9T1 Phase 1 Study

FDA accepts Ortho Dermatologics JEMDEL for Plaque Psoriasis Treatment

Amgen’s BLINCYTO sBLA to be assessed by FDA for treating MRD

FDA paves way for marketing of Viz.AI Contact application